Joana D. Apolonio

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The identification of new biomarkers to differentiate between indolent and aggressive prostate tumors is an important unmet need. We examined the role of THOR (TERT Hypermethylated Oncological Region) as a diagnostic and prognostic biomarker in prostate cancer (PCa).We analyzed THOR in common cancers using genome-wide methylation arrays. Methylation status(More)
  • 1